CN Patent

CN107721902A — 阿普斯特与烟酰胺的共结晶及其制备方法和应用

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2018-02-23 · 8y expired

What this patent protects

本发明涉及阿普斯特与烟酰胺的共结晶及其制备方法。运用X‑射线粉末衍射分析、热失重分析、差示扫描量热分析等手段对共结晶进行了全面表征，发现该共结晶较阿普斯特具有更加优良的物理化学和成药性能。该阿普斯特与烟酰胺的共结晶的制备方法简单，容易控制，重现性好，可以稳定获得阿普斯特与烟酰胺的共结晶。

USPTO Abstract

本发明涉及阿普斯特与烟酰胺的共结晶及其制备方法。运用X‑射线粉末衍射分析、热失重分析、差示扫描量热分析等手段对共结晶进行了全面表征，发现该共结晶较阿普斯特具有更加优良的物理化学和成药性能。该阿普斯特与烟酰胺的共结晶的制备方法简单，容易控制，重现性好，可以稳定获得阿普斯特与烟酰胺的共结晶。

Drugs covered by this patent

Patent Metadata

Patent number
CN107721902A
Jurisdiction
CN
Classification
—
Expires
2018-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Materia Medica of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.